Fed. Circ. Upholds Ax Of Latisse Patent Suit Against Sandoz
The Federal Circuit on Friday affirmed a lower court's dismissal of Allergan's patent suit against Sandoz over planned generic versions of the eyelash growth stimulant Latisse, finding the suit barred because...To view the full article, register now.
Already a subscriber? Click here to view full article